CanSino Biologics Inc. (HKG:6185)
Hong Kong · Delayed Price · Currency is HKD 28.94
-1.16 (-3.85%)
Oct 22, 2026, 4:08 PM HKT
CanSino Biologics Market Cap
CanSino Biologics has a market cap or net worth of 14.14 billion as of October 21, 2026. It is the 7,076th most valuable company in the world and the 349th biggest in Hong Kong. Its market cap has decreased by 6.30% in one year.
Market Cap
14.14B
Enterprise Value
13.14B
Revenue
1.43B
Global Rank
Country Rank
#349 Hong Kong
PE Ratio
152.40
ChartMarket Cap Chart
Since March 28, 2019, CanSino Biologics's market cap has increased from 7.57B to 14.14B, an increase of 86.69%. That is a compound annual growth rate of 8.59%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 22, 2026 | 14.14B | 11.90% |
| Dec 31, 2025 | 12.63B | 8.81% |
| Dec 31, 2024 | 11.61B | -7.23% |
| Dec 29, 2023 | 12.51B | -54.81% |
| Dec 30, 2022 | 27.69B | -58.12% |
| Dec 31, 2021 | 66.11B | -11.16% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Mar 28, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| China Resources Pharmaceutical Group | 29.25B |
| Simcere Pharmaceutical Group | 28.10B |
| China Medical System Holdings | 25.26B |
| Sunshine Lake Pharma | 23.20B |
| Grand Pharmaceutical Group | 16.35B |
| The United Laboratories International Holdings | 14.46B |
| Consun Pharmaceutical Group | 13.46B |
| Fujian Haixi Pharmaceuticals | 11.88B |